Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol

Maldonado N, Rosso-Fernández CM, Portillo-Calderón I, Borreguero Borreguero I, Tristán-Clavijo E, Palacios-Baena ZR, Salamanca E, Fernández-Cuenca F, De-Cueto M, Stolz-Larrieu E, Rodriguez-Baño J, López-Cortés LE. BMJ Open. 2023 Sep 6;13(9):e075699. doi: 10.1136/bmjopen-2023-075699. PMID: 37673453

Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

Federico Becerra-Aparicio 1, Silvia Gómez-Zorrilla 2 3, Marta Hernández-García 1 3, Desiré Gijón 1, Ana Siverio 2 4, Dàmaris Berbel 5, Carlos Sánchez-Carrillo 6, Emilia Cercenado 6 7, Alba Rivera 8, Ana de Malet 9, Mariona Xercavins 10, Enrique Ruiz de Gopegui 3 11, Luis Canoura-Fernández 12, José Antonio Martínez 13, Cristina Seral 14, José Luis Del Pozo 15, Manuel Cotarelo 16, Jazmín Díaz-Regañón 16, Rafael Cantón 1 3, Antonio Oliver 3 11, Juan Pablo Horcajada 2 3, Patricia Ruiz-Garbajosa 1 3. J Antimicrob Chemother. 2023 Sep 5;78(9):2291-2296. doi: 10.1093/jac/dkad234.

Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-Risk Catheter-Related Bloodstream Infection Caused by Coagulase-Negative Staphylococci

Badia-Cebada L, Carmezim J, Pérez-Rodríguez MT, Bereciartua E, López LE, Montenegro MR, Pomar V, Andrés M, Petkova E, Sopena N, Lora-Tamayo J, Monsálvez V, Ramirez-Hidalgo MF, Gómez-Zorrilla S, Boix L, Meije Y, Jiménez E, Gasch O. Antibiotics (Basel). 2023 May 1;12(5):839. doi: 10.3390/antibiotics12050839. PMID: 37237744

Pseudomonas aeruginosa community-onset bloodstream infections: characterization, diagnostic predictors, and predictive score development. Results from the PRO-BAC Cohort

Pedro María Martínez Pérez- Crespo, Álvaro Rojas, Joaquín Felipe Lanz- García, Pilar Retamar-Gentil, Jose María Reguera- Iglesias, Olalla Lima-Rodríguez, Alfonso Del Arco Jiménez, Jonathan Fernández-Suárez, Alfredo Jover-Sáenz, Josune Goikoetxea-Agirre, Eva León Jiménez, Mª Luisa Cantón, Pilar Ortega Lafont, Carlos Armiñanzas Castillo, Juan Sevilla Blanco, Jordi Cuquet Pedragosa, Lucía Boix- Palop, Berta Becerril Carral, Alberto Bahamonde, Teresa Marrodan Ciordia, Clara Natera Kindelán, Isabel María Reche Molina, Carmen Herrero Rodríguez, Inés Pérez Camacho, David Vinuesa, Fátima Galán-Sánchez, Alex Smithson, Esperanza Merino de Lucas, Antonio Sánchez Porto, Marcos Guzmán García, Inmaculada López- Hernández, Jesús Rodríguez Baño *, Luis Eduardo Lopez-Cortes. Antibiotics (Basel). 2022;11(6):707. doi: 10.3390/antibiotics11060707.

Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones

Anna Carrera-Salinas, Aida González-Díaz, Daniel Antonio Vázquez-Sánchez, Mariana Camoez, Jordi Niubó, Jordi Càmara, Carmen Ardanuy, Sara Martí, M Ángeles Domínguez; REIPI/GEIH Study Groups Res Microbiol. 2022;173(3):103921. doi: 10.1016/j.resmic.2022.103921. Epub 2022 Jan 26.

Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project

Marco Mussa, Pedro María Martínez Pérez-Crespo, Luis Eduardo Lopez-Cortes, Pilar Retamar-Gentil, Adrián Sousa-Dominguez, Ane Josune Goikoetxea-Aguirre, José María Reguera-Iglesias, Eva León Jiménez, Isabel Fernández-Natal, Carlos Armiñanzas-Castillo, Lucía Boix-Palop, Jordi Cuquet-Pedragosa, Miguel Ángel Morán Rodríguez, Jonathan Fernandez-Suarez, Alfonso Del Arco-Jiménez, Alfredo Jóver-Saenz, Alberto Bahamonde-Carrasco, Fátima Galan-Sanchez, Juan Manuel Sánchez-Calvo, Alejandro Smithson-Amat, David Vinuesa-García, Antonio Sánchez-Porto, Inmaculada López-Hernández, Jesús Rodríguez-Baño; PROBAC REIPI/GEIH-SEIMC/SAEI group. Microbiol Spectr. 2022;10(4):e0005122. doi: 10.1128/spectrum.00051-22. Epub 2022 Jun 30.

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277.

Ver/Descargar

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?. Infect Dis Ther. 2021 Dec;10(4):2677-2699. doi: 10.1007/s40121-021-00537-0. Epub 2021 Oct 9.PMID: 3462634

Ver/Descargar

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?. Infect Dis Ther. 2021;10(4):2677-2699. doi: 10.1007/s40121-021-00537-0.

Ver/Descargar

Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study). Int J Antimicrob Agents. 2021 Jul;58(1):106352. doi: 10.1016/j.ijantimicag.2021.106352. Epub 2021 May 4. PMID: 33961992.

Ver/Descargar

1 2 3 4

Artículos

Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol

Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-Risk Catheter-Related Bloodstream Infection Caused by Coagulase-Negative Staphylococci

Pseudomonas aeruginosa community-onset bloodstream infections: characterization, diagnostic predictors, and predictive score development. Results from the PRO-BAC Cohort

Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones

Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277.

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?. Infect Dis Ther. 2021;10(4):2677-2699. doi: 10.1007/s40121-021-00537-0.

Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study). Int J Antimicrob Agents. 2021 Jul;58(1):106352. doi: 10.1016/j.ijantimicag.2021.106352. Epub 2021 May 4. PMID: 33961992.

HAZTE SOCIO

BLOGROLL

RECIBE LAS NOTICIAS POR CORREO ELECTRÓNICO

FOLLOW ME ON TWITTER